FDA researchers find promise in custom medical queries to identify safety signals
Regulatory NewsFerdous Al-Faruque
Adverse eventsBiologics/ biosimilars/ vaccinesCBERCDERPharmaceuticalsRegulatory Intelligence/PolicyUnited StatesUS Food and Drug Administration (FDA)